Pieper Steven bought XERS
January 30, 2026 · Form 4 insider transaction
Pieper Steven bought 154,986 shares of Xeris Biopharma Holdings, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
154,986
Price
$0.00
Total value
N/A
InsiderPieper Steven
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJanuary 30, 2026
Filing dateFebruary 2, 2026
Shares owned after1,572,547
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares were acquired pursuant to a restricted stock unit grant under the Company's 2018 Stock Option and Incentive Plan (the "Plan"). Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years, subject to continued employment through such vesting date.